Century Therapeutics
IPSC
IPSC
63 hedge funds and large institutions have $69.5M invested in Century Therapeutics in 2023 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 16 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
12% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 17
35% less capital invested
Capital invested by funds: $107M → $69.5M (-$37.4M)
Holders
63
Holding in Top 10
–
Calls
$26K
Puts
$7K
Top Buyers
| 1 | +$2.89M | |
| 2 | +$1.13M | |
| 3 | +$689K | |
| 4 |
NYLIM
New York Life Investment Management
New York
|
+$464K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$212K |
Top Sellers
| 1 | -$6.08M | |
| 2 | -$2.55M | |
| 3 | -$784K | |
| 4 |
Millennium Management
New York
|
-$532K |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$421K |